CN1194752C - 一种抗病毒中药组合物及制备方法 - Google Patents
一种抗病毒中药组合物及制备方法 Download PDFInfo
- Publication number
- CN1194752C CN1194752C CNB031432115A CN03143211A CN1194752C CN 1194752 C CN1194752 C CN 1194752C CN B031432115 A CNB031432115 A CN B031432115A CN 03143211 A CN03143211 A CN 03143211A CN 1194752 C CN1194752 C CN 1194752C
- Authority
- CN
- China
- Prior art keywords
- radix
- herba
- ethanol
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 230000002155 anti-virotic effect Effects 0.000 title claims description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000002775 capsule Substances 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 47
- 241000628997 Flos Species 0.000 claims description 19
- 239000010231 banlangen Substances 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 241000196133 Dryopteris Species 0.000 claims description 18
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 18
- 210000000582 semen Anatomy 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 16
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 239000000341 volatile oil Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 7
- 238000002481 ethanol extraction Methods 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- -1 electuary Substances 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 102000011759 adducin Human genes 0.000 claims description 3
- 108010076723 adducin Proteins 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 12
- 210000004072 lung Anatomy 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 241000315672 SARS coronavirus Species 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 238000001784 detoxification Methods 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- 231100001274 therapeutic index Toxicity 0.000 abstract description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- 240000004510 Agastache rugosa Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000196131 Dryopteris filix-mas Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 206010035148 Plague Diseases 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241001165494 Rhodiola Species 0.000 abstract 1
- 241000607479 Yersinia pestis Species 0.000 abstract 1
- 239000003205 fragrance Substances 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 238000003809 water extraction Methods 0.000 description 5
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 4
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 4
- 230000000069 prophylactic effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 3
- 150000004056 anthraquinones Chemical class 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229960002179 ephedrine Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- GGHMUJBZYLPWFD-UHFFFAOYSA-N patchoulialcohol Chemical compound C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000001846 repelling effect Effects 0.000 description 2
- 230000001932 seasonal effect Effects 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- JNDPLDZUOFZXIG-UHFFFAOYSA-N 5,7-dihydroxy-3-(5-hydroxy-2,2-dimethylchromen-6-yl)-2,3-dihydrochromen-4-one Chemical compound C1OC2=CC(O)=CC(O)=C2C(=O)C1C1=CC=C2OC(C)(C)C=CC2=C1O JNDPLDZUOFZXIG-UHFFFAOYSA-N 0.000 description 1
- 241001529821 Agastache Species 0.000 description 1
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 229930194248 Licoflavone Natural products 0.000 description 1
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 1
- JNDPLDZUOFZXIG-ZDUSSCGKSA-N Licoisoflavanone Natural products O=C1[C@H](c2c(O)c3c(OC(C)(C)C=C3)cc2)COc2c1c(O)cc(O)c2 JNDPLDZUOFZXIG-ZDUSSCGKSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 239000006001 Methyl nonyl ketone Substances 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- GGHMUJBZYLPWFD-MYYUVRNCSA-N Patchouli alcohol Natural products O[C@@]12C(C)(C)[C@H]3C[C@H]([C@H](C)CC1)[C@]2(C)CC3 GGHMUJBZYLPWFD-MYYUVRNCSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ILRCGYURZSFMEG-RKQHYHRCSA-N Salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RKQHYHRCSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Natural products CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 150000004777 chromones Chemical class 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- 229940089454 lauryl aldehyde Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 238000011020 pilot scale process Methods 0.000 description 1
- 239000001738 pogostemon cablin oil Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000009254 shuang-huang-lian Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031432115A CN1194752C (zh) | 2003-07-01 | 2003-07-01 | 一种抗病毒中药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031432115A CN1194752C (zh) | 2003-07-01 | 2003-07-01 | 一种抗病毒中药组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1483463A CN1483463A (zh) | 2004-03-24 |
CN1194752C true CN1194752C (zh) | 2005-03-30 |
Family
ID=34155749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031432115A Expired - Lifetime CN1194752C (zh) | 2003-07-01 | 2003-07-01 | 一种抗病毒中药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1194752C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446314A (zh) * | 2012-06-02 | 2013-12-18 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗乙型流感的药物中的应用 |
CN109813879A (zh) * | 2017-11-21 | 2019-05-28 | 石家庄以岭药业股份有限公司 | 一种中药组合物的生物检测方法 |
CN114377086A (zh) * | 2020-04-07 | 2022-04-22 | 山东步长制药股份有限公司 | 一种宣肺败毒的中药 |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1329072C (zh) * | 2005-11-23 | 2007-08-01 | 赵剑锋 | 一种治疗小儿发热咳嗽的药物及其制备方法 |
CN101450137B (zh) * | 2007-11-30 | 2012-05-30 | 河北以岭医药研究院有限公司 | 一种抗病毒中药组合物的制备方法 |
CN101564458B (zh) * | 2008-04-24 | 2014-01-29 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗支气管炎药物中的应用 |
CN101637529B (zh) * | 2008-07-29 | 2013-03-27 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗手足口病药物中的应用 |
CN101637530B (zh) * | 2008-07-29 | 2013-03-27 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗荨麻疹药物中的应用 |
CN101658568B (zh) * | 2008-08-25 | 2012-09-05 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗肺原性心脏病药物中的应用 |
CN101683423B (zh) * | 2008-09-26 | 2012-10-17 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗水痘药物中的应用 |
CN101683420B (zh) * | 2008-09-26 | 2013-08-07 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗急性咽炎药物中的应用 |
CN101683424B (zh) * | 2008-09-26 | 2013-08-07 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗扁桃体炎药物中的应用 |
CN101683421B (zh) * | 2008-09-26 | 2013-02-27 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗小儿反复呼吸道感染药物中的应用 |
CN101732467B (zh) * | 2008-11-10 | 2013-02-27 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗化脓性胸膜炎药物中的应用 |
CN101732468B (zh) * | 2008-11-10 | 2014-04-23 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗流行性腮腺炎药物中的应用 |
CN101862391B (zh) * | 2009-04-17 | 2014-12-17 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗人禽流感药物中的应用 |
CN101991694B (zh) * | 2009-08-25 | 2016-05-18 | 北京以岭药业有限公司 | 一种中药组合物在制备抗甲型h1n1流感病毒的药物中的应用 |
CN101940628B (zh) * | 2010-08-14 | 2012-05-23 | 中国农业科学院兰州畜牧与兽药研究所 | 治疗畜禽实热证的中药复方药物 |
CN102379957A (zh) * | 2010-09-03 | 2012-03-21 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗带状疱疹药物中的应用 |
CN102283978B (zh) * | 2011-08-30 | 2013-12-25 | 姚存利 | 一种治疗慢性鼻炎的中药 |
CN103239548B (zh) * | 2012-02-04 | 2016-08-24 | 北京以岭药业有限公司 | 一种中药组合物在制备抗栓药物中的应用 |
CN103251725B (zh) * | 2012-02-15 | 2017-07-21 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗角膜炎药物中的应用 |
CN102526209B (zh) * | 2012-03-06 | 2013-08-21 | 海南灵康制药有限公司 | 一种中药固体制剂(剂型) |
CN103566006B (zh) * | 2012-07-31 | 2017-09-19 | 北京以岭药业有限公司 | 一种中药组合物在制备破坏细菌生物膜的药物中的应用 |
CN103800523B (zh) * | 2012-11-13 | 2018-09-25 | 河北以岭医药研究院有限公司 | 一种抗病毒中药组合物的制备方法及指纹图谱的测定方法 |
CN103845496B (zh) * | 2012-12-06 | 2018-11-02 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备治疗中耳炎的药物中的应用 |
CN104101657B (zh) * | 2013-04-02 | 2017-04-12 | 石家庄以岭药业股份有限公司 | 中药组合物制剂中多种成分含量的测定方法 |
CN104367688B (zh) * | 2013-08-12 | 2019-12-24 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备破坏肺炎克雷伯菌生物膜的药物中的应用 |
CN105079226A (zh) * | 2014-05-22 | 2015-11-25 | 北京以岭药业有限公司 | 一种中药组合物在制备抗中东新型冠状病毒药物中的应用 |
CN105125905A (zh) * | 2015-08-28 | 2015-12-09 | 周香玲 | 一种治疗咳嗽的中药组合物 |
CN105012650A (zh) * | 2015-09-03 | 2015-11-04 | 哈尔滨和谐旺科技开发有限公司 | 一种快速治疗病毒性感冒的中药 |
CN107149623B (zh) * | 2016-03-03 | 2021-03-12 | 石家庄以岭药业股份有限公司 | 一种中药组合物的含量测定方法 |
CN107153098B (zh) * | 2016-03-03 | 2021-05-04 | 石家庄以岭药业股份有限公司 | 一种中药组合物的指纹图谱的测定方法 |
CN105748989B (zh) * | 2016-03-14 | 2020-03-10 | 赵剑锋 | 一种抗菌抗病毒的组合物及其制备方法 |
CN105748695A (zh) * | 2016-04-28 | 2016-07-13 | 徐州天意动物药业有限公司 | 一种用于治疗鸡风热感冒的中药组合物 |
CN109422780B (zh) | 2017-09-05 | 2021-07-13 | 北京以岭药业有限公司 | 一种中药组合物中十八种成分的分离方法 |
CN109668969B (zh) * | 2017-10-13 | 2020-08-14 | 石家庄以岭药业股份有限公司 | 一种中药组合物的气相色谱检测方法 |
CN109668970B (zh) * | 2017-10-13 | 2020-11-10 | 石家庄以岭药业股份有限公司 | 一种中药组合物的超高效液相色谱检测方法 |
CN112076262B (zh) * | 2020-02-04 | 2021-09-17 | 石家庄以岭药业股份有限公司 | 一种中药组合物在制备预防和治疗新型冠状病毒感染肺炎药物中的应用 |
CN111920923A (zh) * | 2020-06-05 | 2020-11-13 | 陶鹤 | 一种用于治疗新型冠状病毒引起的疾病的药物 |
CN111803583A (zh) * | 2020-06-09 | 2020-10-23 | 万天石 | 抗病毒中药组合物、其制备方法及其用途 |
CN114099584A (zh) * | 2020-08-28 | 2022-03-01 | 石家庄以岭药业股份有限公司 | 一种含鱼腥草的抗病毒抗菌中药组合物及其制备方法和应用 |
CN114272292A (zh) * | 2020-09-28 | 2022-04-05 | 石家庄以岭药业股份有限公司 | 一种含麻黄的抗菌抗病毒中药组合物及其制备方法和应用 |
CN115317542A (zh) * | 2021-05-11 | 2022-11-11 | 河北以岭医药研究院有限公司 | 一种中药组合物在制备抗s蛋白d614g突变型新冠病毒药物中的应用 |
CN115429831A (zh) * | 2021-06-01 | 2022-12-06 | 河北以岭医药研究院有限公司 | 一种具有治疗儿童感冒功效的中药组合物及其应用 |
-
2003
- 2003-07-01 CN CNB031432115A patent/CN1194752C/zh not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446314A (zh) * | 2012-06-02 | 2013-12-18 | 北京以岭药业有限公司 | 一种中药组合物在制备治疗乙型流感的药物中的应用 |
CN109813879A (zh) * | 2017-11-21 | 2019-05-28 | 石家庄以岭药业股份有限公司 | 一种中药组合物的生物检测方法 |
CN114377086A (zh) * | 2020-04-07 | 2022-04-22 | 山东步长制药股份有限公司 | 一种宣肺败毒的中药 |
Also Published As
Publication number | Publication date |
---|---|
CN1483463A (zh) | 2004-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1194752C (zh) | 一种抗病毒中药组合物及制备方法 | |
Lee et al. | Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis | |
Jalali et al. | A pharmacology‐based comprehensive review on medicinal plants and phytoactive constituents possibly effective in the management of COVID‐19 | |
Türkdoğan et al. | The role of Urtica dioica and Nigella sativa in the prevention of carbon tetrachloride‐induced hepatotoxicity in rats | |
Gajewski et al. | Potential of herbal products in prevention and treatment of COVID-19. Literature review | |
CN113244296B (zh) | 一种药物挥发油组合物及其制备方法和应用 | |
CN1698750A (zh) | 一种治疗咽炎的中药 | |
CN101152324A (zh) | 一种制备鱼金组合物的方法及含有鱼金组合物的药物 | |
Huang et al. | Chinese herbal medicine for acute upper respiratory tract infections and reproductive safety: a systematic review | |
CN103386022B (zh) | 一种治疗结核性胸膜炎的中药组合物 | |
CN101683420B (zh) | 一种中药组合物在制备治疗急性咽炎药物中的应用 | |
CN111569035A (zh) | 一种中药组合物及其在制备治疗新冠肺炎尤其是无症状感染者药物中的应用 | |
CN101564458A (zh) | 一种中药组合物在制备治疗支气管炎药物中的应用 | |
CN101569712A (zh) | 一种治疗感冒风寒的中药组合物 | |
CN103520439A (zh) | 一种治疗热毒蕴结型慢性骨髓炎的中药及其制备方法 | |
CN107890486B (zh) | 一种中药外用消炎制剂及其制备方法和应用 | |
CN1278709C (zh) | 一种治疗感冒的药物及其制备方法 | |
CN1418674A (zh) | 一种治疗痤疮的药物组合物及制备方法 | |
Rawat et al. | Urtica dioica (Stinging Nettle): A Pharmacologically Important Medicinal Plant Species of Himalayan Region | |
CN113101331B (zh) | 一种百里香药茶及其制备方法和应用 | |
CN116211933B (zh) | 一种抗球虫病的中药组合物及其应用 | |
CN103463401B (zh) | 小儿用哮喘药 | |
Tang et al. | Recent advances in the antiviral activity of Forsythiae Fructus. TMR Integr Med. 2023; 7: e23014. doi: 10.53388/TMRIM202307014 | |
CN113521206B (zh) | 一种含有牛蒡子的中药组合物 | |
CN107669764A (zh) | 中西结合治疗支气管炎的药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHIJIAZHUANG YILING MEDICINE CO., LTD. Free format text: FORMER OWNER: HEBEI YILING MEDICINE INST. CO., LTD. Effective date: 20080516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080516 Address after: No. 238 Tianshan Street, Hebei, Shijiazhuang Patentee after: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. Address before: No. 238 Tianshan Street, Shijiazhuang Development Zone, Hebei Patentee before: HEBEI YILING MEDICINE RESEARCH INSTITUTE Co.,Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090320 Address after: No. 19, Tianhe West Road, Beijing biological engineering and pharmaceutical industry base, Huangcun Town, Beijing, Daxing District Patentee after: BEIJING YILING PHARMACEUTICAL Co.,Ltd. Address before: No. 238 Tianshan Street, Hebei, Shijiazhuang Patentee before: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING YILING PHARMACY CO., LTD. Free format text: FORMER OWNER: SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Effective date: 20090320 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200731 Address after: 050035 No. 238 Tianshan Avenue, Shijiazhuang hi tech Development Zone, Hebei, China Co-patentee after: BEIJING YILING PHARMACEUTICAL Co.,Ltd. Patentee after: Shijiazhuang Yiling Pharmaceutical Co.,Ltd. Address before: 102600 Beijing Huang Cun town, Beijing biological engineering and pharmaceutical industry base, Tianhe West Road, No. 19, Daxing District Patentee before: BEIJING YILING PHARMACEUTICAL Co.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050330 |